ERBB2 and neoplasm: The most widely used approach for the assessment of HER2 expression on CTCs through IF is the CellSearch® system, in which the CellSearch® tumor phenotyping reagent HER2/NEU assay (Menarini Silicon Biosystems) is incorporated into the staining cocktail.